HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical Therapy

Recruiting Observational Study
Periodontal Diseases Periodontitis Gingivitis; Chronic
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Observational
Participants needed
180 (estimated)
Sponsor
Ömer Faruk Okumuş · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This observational clinical study aims to investigate the relationship between the HALP score (Hemoglobin × Albumin × Lymphocyte / Platelet), several blood-based inflammatory indices (including NLR, PLR, LMR, and SII), and salivary MMP-8 levels in individuals with periodontal health, gingivitis, and stage III/IV periodontitis. The study also evaluates how these biomarkers relate to healing followi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged 18-65 years * Ability to provide informed consent * No systemic diseases or conditions affecting periodontal status * For Healthy Group: Probing depth ≤3 mm, no attachment loss, no radiographic bone loss * For Gingivitis Group: Gingival inflammation and bleeding on…
Contacts

Ömer Faruk Okumuş, Assistant Professor

+905532140969

okumus.omer24@gmail.com

CONTACT